Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study.
Yi-Fen LeiHsiu-Chen LinHsiu-Li LinYow-Sheng UangHui-Wen ChengLi-Hsuan WangPublished in: International journal of chronic obstructive pulmonary disease (2020)
This study demonstrated that an increase in the cumulative exposure of statins and fibrates significantly reduced the risk of COPD in patients with hyperlipidemia, and the risk reduction appeared to be significantly dose dependent.